Literature DB >> 11955595

Asymmetric ligand recognition by the activating natural killer cell receptor NKG2D, a symmetric homodimer.

Roland K Strong1.   

Abstract

Natural killer (NK) cells function through a diverse array of cell-surface natural killer receptors (NCRs). NCRs specific for classical and non-classical MHC class I proteins, expressed in complex patterns of inhibitory and activating isoforms on overlapping, but distinct, subsets of NK cells, play an important role in immunosurveillance against cells that have reduced MHC class I expression as a result of infection or transformation. Another NCR, NKG2D, is an activating NCR first identified on NK cells, but subsequently found on macrophages and a variety of T cell types. NKG2D ligands in rodents include the MHC class I-like proteins RAE-1 and H60 and, in humans, ULBPs and the cell stress-inducible proteins MICA and MICB. NKG2D-MIC and -RAE-1 recognition events have been implicated in anti-viral and -tumor immune responses. Crystallographic analyses of NKG2D-MICA and -RAE-1 complexes reveal an unusual mode of recognition that apparently tolerates a surprising degree of ligand plasticity while generating affinities that are among the strongest TCR- or NCR-ligand affinities, thus, far described.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11955595     DOI: 10.1016/s0161-5890(02)00032-9

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  16 in total

Review 1.  Cytomegalovirus microRNAs.

Authors:  Lauren Hook; Meaghan Hancock; Igor Landais; Robert Grabski; William Britt; Jay A Nelson
Journal:  Curr Opin Virol       Date:  2014-04-23       Impact factor: 7.090

2.  The SCHOOL of nature: I. Transmembrane signaling.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-01

3.  The SCHOOL of nature: III. From mechanistic understanding to novel therapies.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-06-11

4.  Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors.

Authors:  Shengjun Lu; Jinyu Zhang; Dai Liu; Guangfu Li; Kevin F Staveley-O'Carroll; Zihai Li; Jennifer D Wu
Journal:  Clin Cancer Res       Date:  2015-06-23       Impact factor: 12.531

5.  Glycosylation contributes to variability in expression of murine cytomegalovirus m157 and enhances stability of interaction with the NK-cell receptor Ly49H.

Authors:  Natalya V Guseva; Colleen A Fullenkamp; Paul W Naumann; Michael R Shey; Zuhair K Ballas; Jon C D Houtman; Catherine A Forbes; Anthony A Scalzo; Jonathan W Heusel
Journal:  Eur J Immunol       Date:  2010-09       Impact factor: 5.532

6.  Obstructing shedding of the immunostimulatory MHC class I chain-related gene B prevents tumor formation.

Authors:  Jennifer D Wu; Catherine L Atteridge; Xuanjun Wang; Tsukasa Seya; Stephen R Plymate
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

7.  The NKG2D ligands RAE-1δ and RAE-1ε differ with respect to their receptor affinity, expression profiles and transcriptional regulation.

Authors:  Oriane Cédile; Natalia Popa; Frédéric Pollet-Villard; Nicolas Garmy; El Chérif Ibrahim; José Boucraut
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

Review 8.  The NKG2D receptor: immunobiology and clinical implications.

Authors:  Steven J Burgess; Kerima Maasho; Madhan Masilamani; Sriram Narayanan; Francisco Borrego; John E Coligan
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

9.  Crystal structure of the cowpox virus-encoded NKG2D ligand OMCP.

Authors:  Eric Lazear; Lance W Peterson; Chris A Nelson; Daved H Fremont
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

Review 10.  Structural biology of shared cytokine receptors.

Authors:  Xinquan Wang; Patrick Lupardus; Sherry L Laporte; K Christopher Garcia
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.